Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$20,019 Mln
Revenue (TTM)
$129,664 Mln
Net Profit (TTM)
$1,188 Mln
ROE
0.1 %
ROCE
4 %
P/E Ratio
16.9
P/B Ratio
1.2
Industry P/E
--
EV/EBITDA
0
Div. Yield
2.1 %
Debt to Equity
0.7
Book Value
$146.7
EPS
$9.9
Face value
--
Shares outstanding
120,054,462
CFO
$32,399.00 Mln
EBITDA
$38,531.00 Mln
Net Profit
$21,470.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Humana (HUM)
| -31.1 | -7.4 | -31.1 | -33.4 | -28.6 | -15.6 | -0.5 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P 100
| -7.4 | -4.4 | -6.8 | 17.6 | 19.5 | 11.9 | 13.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Humana (HUM)
| 1.0 | -44.3 | -10.6 | 10.4 | 13.8 | 12.7 | 28.9 |
|
S&P 100
| 18.7 | 29.0 | 30.8 | -22.1 | 27.6 | 19.3 | 29.5 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Humana (HUM)
|
176.4 | 20,018.9 | 129,664.0 | 1,188.0 | 1.6 | 7 | 16.9 | 1.2 |
| 18.7 | 3,442.4 | 3,948.7 | -0.7 | 0.4 | -0.5 | -- | 19.8 | |
| 34.9 | 15,638.4 | 194,777.0 | -6,673.0 | -3.3 | -28.8 | -- | 0.8 | |
| 269.0 | 68,939.8 | 274,952.0 | 5,957.0 | 3.4 | 14.4 | 11.6 | 1.7 | |
| 1.8 | 902.4 | 1,924.3 | -85.6 | -4.4 | -26.3 | -- | 3.2 | |
| 298.4 | 62,854.5 | 199,125.0 | 5,662.0 | 4.1 | 13.3 | 11.3 | 1.5 | |
| 22.4 | 12,800.6 | 19,628.0 | 978.0 | 9.1 | 6.8 | 11.4 | 0.8 | |
| 137.9 | 6,848.4 | 45,426.0 | 472.0 | 1.7 | 11 | 14.8 | 1.8 | |
| 16.5 | 1,389.9 | 1,288.7 | 58.5 | 7.2 | 12.5 | 26.1 | 2.9 | |
| 275.2 | 237,620.5 | 447,567.0 | 12,056.0 | 4.2 | 12.9 | 19.8 | 2.5 |
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits,... including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Address: Humana Building, Louisville, KY, United States, 40202 Read more
CEO & Director
Mr. Bruce Dale Broussard
Chief Financial Officer
Ms. Susan Marie Diamond
Headquarters
Louisville, KY
Website
The share price of Humana Inc (HUM) is $176.44 (NYSE) as of 02-Apr-2026 14:43 EDT. Humana Inc (HUM) has given a return of -28.64% in the last 3 years.
The P/E ratio of Humana Inc (HUM) is 16.87 times as on 31-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.94
|
1.75
|
|
2024
|
25.38
|
1.87
|
|
2023
|
22.52
|
3.45
|
|
2022
|
22.93
|
4.20
|
|
2021
|
20.34
|
3.70
|
The 52-week high and low of Humana Inc (HUM) are Rs 315.35 and Rs 163.11 as of 03-Apr-2026.
Humana Inc (HUM) has a market capitalisation of $ 20,019 Mln as on 31-Mar-2026. As per SEBI classification, it is a Large Cap company.
Before investing in Humana Inc (HUM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.